BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2773932)

  • 1. A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
    Markert ML; Norby-Slycord C; Ward FE
    Am J Hum Genet; 1989 Sep; 45(3):354-61. PubMed ID: 2773932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
    Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.
    Valerio D; Dekker BM; Duyvesteyn MG; van der Voorn L; Berkvens TM; van Ormondt H; van der Eb AJ
    EMBO J; 1986 Jan; 5(1):113-9. PubMed ID: 3007108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
    Markert ML; Hutton JJ; Wiginton DA; States JC; Kaufman RE
    J Clin Invest; 1988 May; 81(5):1323-7. PubMed ID: 3366897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
    Bonthron DT; Markham AF; Ginsburg D; Orkin SH
    J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
    Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
    Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
    Hirschhorn R; Ellenbogen A
    Am J Hum Genet; 1986 Jan; 38(1):13-25. PubMed ID: 3946419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of nine RFLPs at the adenosine deaminase (ADA) locus.
    Tzall S; Ellenbogen A; Eng F; Hirschhorn R
    Am J Hum Genet; 1989 Jun; 44(6):864-75. PubMed ID: 2567118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
    Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
    J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution.
    Orkin SH; Goff SC; Kelley WN; Daddona PE
    Mol Cell Biol; 1985 Apr; 5(4):762-7. PubMed ID: 3838797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
    Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
    J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients.
    Berkvens TM; van Ormondt H; Gerritsen EJ; Khan PM; van der Eb AJ
    Genomics; 1990 Aug; 7(4):486-90. PubMed ID: 1696926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hot spot mutations in adenosine deaminase deficiency.
    Hirschhorn R; Tzall S; Ellenbogen A
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6171-5. PubMed ID: 2166947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.
    Herbschleb-Voogt E; Pearson PL; Vossen JM; Meera Khan P
    Hum Genet; 1981; 56(3):379-86. PubMed ID: 7239521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.
    Akeson AL; Wiginton DA; Dusing MR; States JC; Hutton JJ
    J Biol Chem; 1988 Nov; 263(31):16291-6. PubMed ID: 3182793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic cell genetics of adenosine deaminase expression and severe combined immunodeficiency disease in humans.
    Koch G; Shows TB
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4211-5. PubMed ID: 6933468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal and mutant human adenosine deaminase genes.
    Akeson AL; Wiginton DA; Hutton JJ
    J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cDNA and amino acid sequence of human adenosine deaminase.
    Daddona PE; Orkin SH; Shewach DS; Kelley WN
    Ann N Y Acad Sci; 1985; 451():238-44. PubMed ID: 3878119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.